您使用提示模式 关闭

BTEC - iShares Nasdaq US Biotechnology UCITS ETF (IE00BYXG2H39)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

使用 Cbonds Watchlist 查找、保存和跟踪投资工具

有了 Cbonds Watchlist,您可以随时了解投资信息,做出明智决策!

Watchlist
需要 访问
 
(%)
IE00BYXG2H39
BTEC ISIN
交易所交易基金 (ETF)
基金类型
BlackRock
提供商
-
每股资产净值
2017-10-19
成立日期
股息的支付
CEOGMS
CFI
BTEC
代码
Formed
Status
Equity
投资项目
Biotech
部门
USA
地区分布
Nasdaq Biotechnology Index
基准
0.35 %
总成本比率
1.156,96 百万 USD
基金资产总量 | 2026-08-12
1.078,65 百万 USD
股票类资产 | 2026-08-12
UCITS

最新数据在
添加比较项目

报价 (BTEC)

探索最全面的数据库

1 000 000

债券

100 000

股票

175 910

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件

价格动态的变化

Fund profile

The iShares Nasdaq US Biotechnology UCITS ETF seeks to replicate as close as possible the price and yield performance of the NASDAQ Biotechnology Index by investing in a portfolio comprised primarily of biotechnology and pharmaceutical equities listed on the NASDAQ

BTEC profile

The iShares Nasdaq US Biotechnology UCITS ETF is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The BlackRock fund’s base currency is USD and the share class was registered 19.10.2017 with unique ISIN - IE00BYXG2H39. Main exchange is London S.E. (USD) and ticker symbol is BTEC. The total expense ratio is 0.35%. The iShares Nasdaq US Biotechnology UCITS ETF pays dividends 0 time(s) per year.

结构 BTEC 在 2026-07-28

证券
AMGEN INC 8,57%
VERTEX PHARMACEUTICALS INC 8,05%
GILEAD SCIENCES INC 7,34%
REGENERON PHARMACEUTICALS INC 5,02%
REVOLUTION MEDICINES INC 2,74%
ALNYLAM PHARMACEUTICALS INC 2,7%
BIOGEN INC 2,13%
ILLUMINA INC 2,05%
ROYALTY PHARMA PLC CLASS A 1,86%
INCYTE CORP 1,82%
ROIVANT SCIENCES LTD 1,71%
ARGENX SE ADR 1,69%
INSMED INC 1,58%
UNITED THERAPEUTICS CORP 1,56%
MODERNA INC 1,55%
VIATRIS INC 1,46%
GUARDANT HEALTH INC 1,33%
NEUROCRINE BIOSCIENCES INC 1,29%
BRIDGEBIO PHARMA INC 1,17%
MEDPACE HOLDINGS INC 1,14%
JAZZ PHARMACEUTICALS PLC 1,13%
ASCENDIS PHARMA 1,1%
EXELIXIS INC 1%
MADRIGAL PHARMACEUTICALS INC 0,87%
ARROWHEAD PHARMACEUTICALS INC 0,85%
AXSOME THERAPEUTICS INC 0,85%
BIOMARIN PHARMACEUTICAL INC 0,84%
BEONE MEDICINES AG 0,76%
CYTOKINETICS INC 0,75%
BIONTECH SE ADR 0,75%
KRYSTAL BIOTECH INC 0,75%
SANOFI ADR REPRESENTING SA 0,74%
HALOZYME THERAPEUTICS INC 0,69%
SUMMIT THERAPEUTICS INC 0,68%
IONIS PHARMACEUTICALS INC 0,64%
CRINETICS PHARMACEUTICALS INC 0,62%
PROTAGONIST THERAPEUTICS INC 0,62%
KYMERA THERAPEUTICS INC 0,61%
SPYRE THERAPEUTICS INC 0,61%
ALKERMES 0,59%
APOGEE THERAPEUTICS INC 0,58%
PRAXIS PRECISION MEDICINES INC 0,58%
IMMUNOVANT INC 0,56%
VAXCYTE INC 0,55%
TEMPUS AI INC CLASS A 0,52%
RHYTHM PHARMACEUTICALS INC 0,52%
IMMUNITYBIO INC 0,51%
ABIVAX AMERICAN DEPOSITARY SHARES 0,5%
COGENT BIOSCIENCES INC 0,49%
MIRUM PHARMACEUTICALS INC 0,48%
CG ONCOLOGY INC 0,45%
XENON PHARMACEUTICALS INC 0,44%
PTC THERAPEUTICS INC 0,44%
AMNEAL PHARMACEUTICALS INC CLASS A 0,42%
LIGAND PHARMACEUTICALS INC 0,42%
SCHOLAR ROCK HOLDING CORP 0,41%
ERASCA INC 0,4%
TWIST BIOSCIENCE CORP 0,39%
10X GENOMICS INC CLASS A 0,39%
ORUKA THERAPEUTICS INC 0,38%
TRAVERE THERAPEUTICS INC 0,37%
INDIVIOR PHARMACEUTICALS INC 0,35%
CRISPR THERAPEUTICS AG 0,32%
DEFINIUM THERAPEUTICS INC 0,32%
ACADIA PHARMACEUTICALS INC 0,31%
VERACYTE INC 0,31%
CARIS LIFE SCIENCES INC 0,31%
EDGEWISE THERAPEUTICS INC 0,31%
DYNE THERAPEUTICS INC 0,3%
RELAY THERAPEUTICS INC 0,28%
TANGO THERAPEUTICS INC 0,27%
DENALI THERAPEUTICS INC 0,27%
STRUCTURE THERAPEUTICS ADR INC 0,26%
ADAPTIVE BIOTECHNOLOGIES CORP 0,25%
KINIKSA PHARMACEUTICALS INTERNATIO 0,25%
ARCUTIS BIOTHERAPEUTICS INC 0,25%
ENLIVEN THERAPEUTICS INC 0,23%
ALUMIS INC 0,23%
NEWAMSTERDAM PHARMA NV 0,23%
IDEAYA BIOSCIENCES INC 0,22%
MBX BIOSCIENCES INC 0,2%
DISC MEDICINE INC 0,2%
SUPERNUS PHARMACEUTICALS INC 0,19%
GRAIL INC 0,19%
BEAM THERAPEUTICS INC 0,19%
ATAIBECKLEY INC 0,19%
TREVI THERAPEUTICS INC 0,18%
KODIAK SCIENCES INC 0,18%
ULTRAGENYX PHARMACEUTICAL INC 0,18%
NURIX THERAPEUTICS INC 0,18%
TARSUS PHARMACEUTICALS INC 0,18%
BIOCRYST PHARMACEUTICALS INC 0,17%
VERICEL CORP 0,17%
VERA THERAPEUTICS INC CLASS A 0,17%
UNIQURE NV 0,16%
PHARVARIS N V NV 0,16%
MINERALYS THERAPEUTICS INC 0,16%
AMYLYX PHARMACEUTICALS INC 0,15%
GENMAB SPONSORED ADR 0,15%
AGIOS PHARMACEUTICALS INC 0,15%
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权